Literature DB >> 8252361

Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis.

W A Kmiot1, D Youngs, R Tudor, H Thompson, M R Keighley.   

Abstract

A study was performed to investigate whether acute reservoir ileitis (pouchitis) is associated with specific changes in mucosal morphology, crypt cell kinetics and faecal bacteriology in the ileal pouch. Forty-six patients were studied (ileal reservoir, 36; end ileostomy, ten) using clinical grading, sigmoidoscopy and biopsy; 24 patients with a reservoir were restudied after therapy for 1 month with metronidazole 400 mg three times daily. An index of villus atrophy and crypt cell production rate (CCPR) were determined in all biopsy material. Faecal bacteriology was assessed in 12 patients with a pouch before and after metronidazole therapy. The mucosa of patients with pouchitis was associated with a lower villus atrophy index (P = 0.052), a higher CCPR (P = 0.03) and a higher grade of acute inflammation than that in those without pouchitis. There was no difference in faecal bacterial counts between patients with and without pouchitis. A low atrophy index correlated with a high CCPR (P < 0.001), worse functional score (P < 0.001) and more severe pouch mucosal acute inflammation (P < 0.001), but not with faecal bacteriology. Following metronidazole therapy there was resolution of acute pouch inflammation, increased villus atrophy index (P = 0.049), decreased CCPR (P = 0.049) but no differences in faecal bacterial counts apart from Bacteroides species. These data show that metronidazole therapy does not specifically alter the growth of common faecal bacteria in patients with pouchitis, apart from Bacteroides species. However, metronidazole causes resolution of the typical changes in pouch mucosal morphology and crypt cell kinetics associated with pouchitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252361     DOI: 10.1002/bjs.1800801132

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Understanding the pouch microbiota: an evolving story.

Authors:  Laura Harrell Raffals
Journal:  Dig Dis Sci       Date:  2012-11       Impact factor: 3.199

2.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 3.  Surgical prophylaxis of pouchitis in ulcerative colitis.

Authors:  Giuseppe Brisinda; Serafino Vanella; Venanzio Valenza; Anna Crocco; Germano Perotti; Daniela Di Giuda; Giorgio Maria
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

4.  Substance P--an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells.

Authors:  U Keränen; H Järvinen; P Kärkkäinen; T Kiviluoto; E Kivilaakso; S Soinila
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

5.  Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis.

Authors:  A J Kroesen; M Stockmann; C Ransco; J D Schulzke; M Fromm; H J Buhr
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

6.  Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

Authors:  T Kühbacher; S J Ott; U Helwig; T Mimura; F Rizzello; B Kleessen; P Gionchetti; M Blaut; M Campieri; U R Fölsch; M A Kamm; S Schreiber
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

7.  On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials.

Authors:  Behzad Elahi; Shekoufeh Nikfar; Saeed Derakhshani; Mohammad Vafaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-10-17       Impact factor: 3.199

8.  Histopathological evaluation and risk factors related to the development of pouchitis in patients with ileal pouches for ulcerative colitis.

Authors:  Roberta Thiery de Godoy Arashiro; Magaly Gemio Teixeira; Viviane Rawet; Alina Guimarães Quintanilha; Henrique Moura de Paula; Adriano Zanon Silva; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

9.  A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Authors:  Marina L Ritchie; Tamara N Romanuk
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

10.  Gut Microbiota Composition Changes in Constipated Women of Reproductive Age.

Authors:  Hongxia Li; Jianwei Chen; Xiaojing Ren; Chuanli Yang; Shuai Liu; Xinshu Bai; Shuhua Shan; Xiushan Dong
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.